Table 1. CHIKV isolation from tissue homogenates.
mAb | Dose (mg/kg) |
Animal | Tissue Virus Isolation |
---|---|---|---|
SVIR002 (anti-lysozyme control) |
15 | 31559 | Spleen, Finger Joints |
31055 | Finger Joints | ||
31289 | Wrist Joints | ||
31333 | Elbow & Wrist Joints, Hamstring | ||
SVIR001 (anti-CHIKV) |
15 | 31078 | Negative |
31296 | Negative | ||
31312 | Negative | ||
31302 | Negative | ||
5 | 31088 | Negative | |
31335 | Negative | ||
30430 | Negative | ||
31651 | Negative |
Three groups of four animals each were treated with control antibody SVIR002 at 15 mg/kg, SVIR001 at 15 mg/kg, or SVIR001 at 5 mg/kg. To isolate CHIKV from the infected joint and muscle tissues an aliquot of tissue homogenate was incubated in C6/36 cells for four days. Following incubation, infectious virus was recovered by plaque assay on Vero cells. Only the virus isolation-positive tissues are listed. The limit of detection was 1 PFU per ml of C6/36 supernatant.